Literature DB >> 26882261

Inflammatory networks underlying colorectal cancer.

Audrey Lasry1, Adar Zinger1, Yinon Ben-Neriah1.   

Abstract

Inflammation is emerging as one of the hallmarks of cancer, yet its role in most tumors remains unclear. Whereas a minority of solid tumors are associated with overt inflammation, long-term treatment with non-steroidal anti-inflammatory drugs is remarkably effective in reducing cancer rate and death. This indicates that inflammation might have many as-yet-unrecognized facets, among which an indolent course might be far more prevalent than previously appreciated. In this Review, we explore the various inflammatory processes underlying the development and progression of colorectal cancer and discuss anti-inflammatory means for its prevention and treatment.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26882261     DOI： 10.1038/ni.3384

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  162 in total

Review 1.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

Review 2.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

3.  IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).

Authors:  Morten A Karsdal; Georg Schett; Paul Emery; Olivier Harari; Inger Byrjalsen; Andy Kenwright; Anne C Bay-Jensen; Adam Platt
Journal:  Semin Arthritis Rheum       Date:  2012-03-06       Impact factor: 5.532

4.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.

Authors:  Sharon Amit; Ada Hatzubai; Yaara Birman; Jens S Andersen; Etti Ben-Shushan; Matthias Mann; Yinon Ben-Neriah; Irit Alkalay
Journal:  Genes Dev       Date:  2002-05-01       Impact factor: 11.361

5.  Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

Authors:  Kimmie Ng; Jeffrey A Meyerhardt; Andrew T Chan; Kaori Sato; Jennifer A Chan; Donna Niedzwiecki; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Alan P Venook; Shuji Ogino; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2014-11-27       Impact factor: 13.506

Review 6.  Development of anti-TNF therapy for rheumatoid arthritis.

Authors:  Marc Feldmann
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

7.  Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.

Authors:  Jonathan Lévy; Wulfran Cacheux; Medhi Ait Bara; Antoine L'Hermitte; Patricia Lepage; Marie Fraudeau; Coralie Trentesaux; Julie Lemarchand; Aurélie Durand; Anne-Marie Crain; Carmen Marchiol; Gilles Renault; Florent Dumont; Franck Letourneur; Myriam Delacre; Alain Schmitt; Benoit Terris; Christine Perret; Mathias Chamaillard; Jean-Pierre Couty; Béatrice Romagnolo
Journal:  Nat Cell Biol       Date:  2015-07-27       Impact factor: 28.824

8.  Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis.

Authors:  Y Wang; K Wang; G-C Han; R-X Wang; H Xiao; C-M Hou; R-F Guo; Y Dou; B-F Shen; Y Li; G-J Chen
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313

9.  The origins of tumor-promoting inflammation.

Authors:  Tanya Bondar; Ruslan Medzhitov
Journal:  Cancer Cell       Date:  2013-08-12       Impact factor: 31.743

10.  Paneth cells as a site of origin for intestinal inflammation.

Authors:  Timon E Adolph; Michal F Tomczak; Lukas Niederreiter; Hyun-Jeong Ko; Janne Böck; Eduardo Martinez-Naves; Jonathan N Glickman; Markus Tschurtschenthaler; John Hartwig; Shuhei Hosomi; Magdalena B Flak; Jennifer L Cusick; Kenji Kohno; Takao Iwawaki; Susanne Billmann-Born; Tim Raine; Richa Bharti; Ralph Lucius; Mi-Na Kweon; Stefan J Marciniak; Augustine Choi; Susan J Hagen; Stefan Schreiber; Philip Rosenstiel; Arthur Kaser; Richard S Blumberg
Journal:  Nature       Date:  2013-10-02       Impact factor: 49.962
View more
  166 in total

1.  Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.

Authors:  Yue Guo; Zheng-Yuan Su; Chengyue Zhang; John M Gaspar; Rui Wang; Ronald P Hart; Michael P Verzi; Ah-Ng Tony Kong
Journal:  Biochem Pharmacol       Date:  2017-03-04       Impact factor: 5.858

2.  Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer.

Authors:  Z Bai; J Wang; T Wang; Y Li; X Zhao; G Wu; Y Yang; W Deng; Z Zhang
Journal:  Clin Transl Oncol       Date:  2017-07-14       Impact factor: 3.405

Review 3.  Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.

Authors:  Shima Nakanishi; John L Cleveland
Journal:  Amino Acids       Date:  2016-06-29       Impact factor: 3.520

4.  UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer.

Authors:  Jun Yin; Wei Luo; Xiang Zeng; Lisi Zeng; Zhiyang Li; Xiaofang Deng; Xiaojun Tan; Weimin Hu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 5.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

6.  Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer.

Authors:  Shuo Wang; Yuan Qu; Pengyan Xia; Yi Chen; Xiaoxiao Zhu; Jing Zhang; Guan Wang; Yong Tian; Jianming Ying; Zusen Fan
Journal:  Cell Res       Date:  2020-05-04       Impact factor: 25.617

7.  The Adaptor Protein CARD9 Protects against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells.

Authors:  Tingting Wang; Chaogang Fan; Anran Yao; Xingwei Xu; Guoxing Zheng; Yun You; Changying Jiang; Xueqiang Zhao; Yayi Hou; Mien-Chie Hung; Xin Lin
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

8.  Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.

Authors:  Veronika Butin-Israeli; Triet M Bui; Hannah L Wiesolek; Lorraine Mascarenhas; Joseph J Lee; Lindsey C Mehl; Kaitlyn R Knutson; Stephen A Adam; Robert D Goldman; Arthur Beyder; Lisa Wiesmuller; Stephen B Hanauer; Ronen Sumagin
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

9.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.

Authors:  Yue Guo; Renyi Wu; John M Gaspar; Davit Sargsyan; Zheng-Yuan Su; Chengyue Zhang; Linbo Gao; David Cheng; Wenji Li; Chao Wang; Ran Yin; Mingzhu Fang; Michael P Verzi; Ronald P Hart; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

Review 10.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.